Kelsey Kaustinen
Articles by Kelsey Kaustinen
| 2 min read
Peptide drug targets two cancer proteins for increased specificity and uptake
| 3 min read
Genomenon and BC Platforms seek to combine their tech platforms to boost genomic research
| 3 min read
Research reveals that collagen, thought to aid cancer progression, actually fights disease spread
| 3 min read
Combining machine learning and EEG may have identified an imaging biomarker for better treating PTSD and MDD
| 3 min read
Scientists identify a new target for treating age-related eye diseases
| 3 min read
A multi-organization academic team reports on their efforts to combat resistant bacteria with engineered strains
| 3 min read
Cell atlas of tropical disease parasite could highlight new targets for treatment
| 3 min read
Data show full complement ST266 biologic offers better neuroprotection than fractionated formats
| 3 min read
APIS and Moffitt pair up to assess TROLL lncRNAs as predictive biomarkers in cancer
| 3 min read
MorphoSys licenses Hemibody technology from Cherry Biolabs in hopes of improving T cell-based therapeutics
| 3 min read
Puma reports that neratinib improved CNS outcomes in HER2-positive breast cancer patients
| 4 min read
The AMR Action Fund seeks to support antibiotic candidates in massive industry-philanthropic alliance
| 2 min read
Jumpcode details how its CRISPRclean tech unites NGS and CRISPR/Cas editing
| 3 min read
A breath test to rapidly diagnose COVID-19 infection may be on the way from imec
| 3 min read
APIS, University of Virginia hope to leverage HULLK lncRNA as a prostate cancer biomarker
Page 1 of 113 - 1681 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Harnessing liver-on-a-chip models for drug safety
Discover how researchers leverage microphysiological systems in toxicology studies.
Enhancing bioanalytical studies with centralized data management
Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
Explained: How are metabolite biomarkers improving drug discovery and development?
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
